References:
Bellus GA, Mcintosh I, Smith EA, Aylsworth AS, Francomano CA. 1995. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nature Genetics 10(3):357-359.
Brunetti-Pierri N, Andreucci M, Tuzzi R, Vega G, Gray G, McKeown C, Ballabio A, Andria G, Meroni G, Parenti G. 2003. X-linked recessive chondrodysplasia punctata: Spectrum of arylsulfatase E gene mutations and expanded clinical variability. American Journal of Medical Genetics 117A(2):164-168.
Coen A. C. Ottenheijm CCWG. 2009. Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiency. Hum Mol Genet 18:2359-2369.
D. MMV, M. M, P. ABV, V. S, O. RAMR, R. NVR, N. AJA, M. Z, V. EFI, D. LI. 2012. Variable expressivity of osteogenesis imperfecta in a Brazilian family due to p.G1079S mutation in the COL1A1 gene. Genetics & Molecular Research 11(3):3246-3255.
De Jong Pleij EAP, Vos FI, Ribbert LSM, Pistorius LR, Tromp E, Bilardo CM. 2012. Prenasal thickness‐to‐nasal bone length ratio: a strong and simple second‐ and third‐trimester marker for trisomy 21. Ultrasound Obstet Gynecol 39(2).
Deutz-Terlouw PP, Losekoot M, Aalfs CM, Hennekam RCM, Bakker E. 1998. Asn540Thr substitution in the fibroblast growth factor receptor 3 tyrosine kinase domain causing hypochondroplasia. Human Mutation.
Foldynova-Trantirkova S, Wilcox WR, Krejci P. 2012. Sixteen years and counting: The current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Human Mutation 33(1):29-41.
Gay S, Dupuis D, Faivre L, Masurelpaulet A, Labenne M, Colombani M, Soichot P, Huet F, Hainque B, Sternberg D. 2010. Severe neonatal non-dystrophic myotonia secondary to a novel mutation of the voltage-gated sodium channel (SCN4A) gene. American Journal of Medical Genetics Part A 146A(3):380-383.
Georgoulis G, Alexiou G, Prodromou N. 2011. Achondroplasia with synostosis of multiple sutures. American Journal of Medical Genetics Part A 155(8):1969-1971.
Grannum PA, Hobbins JC. 1983. Prenatal diagnosis of fetal skeletal dysplasias. Seminars in Perinatology 7(2):125.
Kaneko H, Kitoh H, Matsuura T, Masuda A, Ito M, Mottes M, Rauch F, Ishiguro N, Ohno K. 2011. Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8. Human Genetics 130(5):p.671-683.
Lehtokari VO, Kiiski K, Sandaradura SA, Laporte J, Ettersson CW. 2014. Mutation Update: The Spectra of Nebulin Variants and Associated Myopathies. Human Mutation 35(12).
Liu Y, Wang L, Yang Y, Liang Y, Wu Q. 2019. Prenatal diagnosis of fetal skeletal dysplasia using targeted next-generation sequencing: an analysis of 30 cases. Diagnostic Pathology 14(1):76.
Lord J, McMullan DJ, Eberhardt RY, Rinck G, Wilson E. 2019. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet 393(10173):747-757.
Matthews E, Manzur AY, Sud R, Muntoni F, Hanna MG. 2011. Stridor as a Neonatal Presentation of Skeletal Muscle Sodium Channelopathy. Archives of Neurology 68(1):127—129.
Miraoui H, Ringe J, Häupl T. 2010. Increased EFG- and PDGFα-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis. Human Molecular Genetics 19(9):p.1678-1689.
Pan C, Tseng Y, Lan T, Chang H. 2017. Craniofacial features of cleidocranial dysplasia. Journal of Dental Sciences:S1991790217301009.
Pauli RM. 2019. Achondroplasia: a comprehensive clinical review. Orphanet Journal of Rare Diseases 14(1).
Petrovski S, Aggarwal V, Giordano JL, Stosic M, Wou K, Bier L, Spiegel E, Brennan K, Stong N, Jobanputra V. 2019. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet 393(10173):758-767.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E. 2015. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine Official Journal of the American College of Medical Genetics 17(5):405-423.
Tang J, Zhou C, Shi H, Mo Y, Luo L. 2020. Prenatal diagnosis of skeletal dysplasias using whole exome sequencing in China. Clinica Chimica Acta 507.
Tarja, Linnankivi, Outi, Mäkitie, Leena, Valanne, Sanna, Toiviainen-Salo. 2012. Neuroimaging and neurological findings in patients with hypochondroplasia andFGFR3N540K mutation. American Journal of Medical Genetics Part A.
W RD, R SJ, M P, S S. 1985. Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta. Journal of Clinical Investigation.
Waller DK, Correa A, Vo TM, Wang Y, Hobbs C, Langlois PH, Pearson K, Romitti PA, Shaw GM, Hecht JT. 2008. The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. American Journal of Medical Genetics Part A 146A(18):2385-2389.
Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, Lemerrer M, Mortier G, Mundlos S, Nishimura G, Rimoin DL. 2011. Nosology and classification of genetic skeletal disorders: 2010 revision. American Journal of Medical Genetics Part A 155(5):943-968.
Willing MC, Cohn DH, Byers PH. 1990. Frameshift mutation near the 3’ end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I. Journal of Clinical Investigation 85(1):282-90.
Wynn J, King TM, Gambello MJ, Waller DK, Hecht JT. 2007. Mortality in achondroplasia study: A 42-year follow-up. American Journal of Medical Genetics Part A 143A(21):2502-2511.
Xue Y, Sun A, Mekikian PB, Martin J, Wilcox WR. 2014. FGFR3 mutation frequency in 324 cases from the International Skeletal Dysplasia Registry. Mol Genet Genomic Med 2(6):497-503.
Yang K, Shen M, Yan Y, Tan Y, Tian Y. 2019. Genetic Analysis in Fetal Skeletal Dysplasias by Trio Whole-Exome Sequencing. BioMed Research International 2019(2):1-8.
Zhu JL, Hasle H, Correa A, Schendel D, Friedman JM, Olsen J, Rasmussen SA. 2013. Survival among people with Down syndrome: a nationwide population-based study in Denmark. Genet Med 15(1):64-9.